×

Pharma firms look to 'speciality' model: Pro

4:00 AM ET Tue, 22 April 2014

Navid Malik, head of life sciences research at Cenkos Securities, discusses M&A activity in the pharmaceutical sector and says firms are narrowing their businesses along strategic lines.